Navigation Links
Booster dose not required for Hepatitis B Vaccination

Alessandro Remo Zanetti and his colleagues from Institute of Virology, Italy has found that Initial vaccination with Hepatitis B produces the required concentrations of circulating antibodies in the blood of the patients for long periods//. The researchers have found that the circulating antibodies against Hepatitis B vaccination are present in the blood for at least 10 years after vaccination. Researchers have concluded that there is no need of booster doses of Hepatitis B in these patients as enough amount of antibodies are present which can give protection in case of Hepatitis B infection. The results of the work have been published in the journal The Lancet.

Viral hepatitis B is a leading cause of acute and chronic liver disease worldwide. The World Health Organization (WHO) estimates that, globally, about 2 billion people have been infected with hepatitis B virus (HBV). More than 350 million people are chronically infected. WHO recommends that all countries should have universal infant or adolescent hepatitis B vaccination integrated into their national immunization programs.

The researchers conducted their trial in 1212 children’s and 446 Italian Air Force Recruits by vaccinating with Hepatitis B vaccination. They found that 64% of children and 89% of the recruits retained protective concentrations of antibodies. The study shows that infant and adolescent immune systems can recall responding to hepatitis B more than 10 years after immunization.

Experts View:

Professor Zanetti concludes: “In light of our findings, the use of routine booster doses of hepatitis B vaccine does not seem necessary to maintain long-term protection in immuno-competent individuals vaccinated as infants and teenagers."

Ding-Shinn Chen, National Taiwan University, Taiwan said, “Unless accumulating data show a significant increase of HBV infection in adolescents or adults who were vaccinated as children, a policy of booster vaccination in a population should not be recommended. We believe that this applies both to hyper-endemic and low endemic areas of the world.”

Source: News wise, The Lancet
'"/>




Related medicine news :

1. Need for Hepatitis Booster Questioned
2. Booster Dose Of Radiotherapy Beneficial In Early Breast Cancer
3. Booster Dose for Chickenpox Vaccine Recommended
4. Care for footwear not required diabetic patients
5. Advanced STD programs required
6. New Stem Cells lines will be required
7. Multi targeted approach required for suicide prevention in adolescents
8. More Funds required for Asian Countries to fight Bird Flu
9. Clergy blasts councilmans required-condom plan
10. Salmeterol - to be used in combination & only when required
11. Vitamin B for Hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... July 24, 2017 , ... ... effectively destroyed the construction site and threatened numerous homes and businesses nearby, causing ... article on NBCLosAngeles.com. Los Angeles Area consulting firm Fire Protection Group, Inc. ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... Axiad ... organizations, today announced it has partnered with WALLIX to expand its solution ... 800-171 . , There are a number of ways to address the authentication requirements ...
(Date:7/24/2017)... ... 24, 2017 , ... Puregraft, the global leader in the ... United States Patent Number 9,695,398 (the '398 patent) and South Korean Patent Number ... '324 patents cover methods and systems for optimizing fat grafts for current and ...
(Date:7/24/2017)... ... 2017 , ... A new report released today by FusionHealth, ... health care at scale, indicates record-breaking adherence results for the company’s obstructive sleep ... pressure (PAP) therapy, the most widely utilized treatment for OSA, typically range between ...
(Date:7/24/2017)... ... July 24, 2017 , ... Committed to eliminating ... enrolled over 100,000 children in their treatment program. Clubfoot is a pervasive problem ... where treatment is limited or non-existent. Without intervention, these children are destined to ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... and EDMONTON, Alberta , ... scientists and the University of Alberta in ... data in Nature,s partner journal, Schizophrenia 1 , ... predict instances of schizophrenia with 74% accuracy. This ... severity of specific symptoms in schizophrenia patients with ...
(Date:7/21/2017)... Did you know that PhRMA member companies invested $65.5 billion in ... brand medicines, generics and the supply chain account for 14 percent ... of this (7 percent)? Or that the United States ... investments in high-growth biopharmaceutical startups? ... The biopharmaceutical industry accounts ...
(Date:7/17/2017)... Fla. , July 17, 2017  MedX Holdings, ... branded medical testing, strengthening and rehabilitation equipment, today announced ... Machine Program. MedX is considered the gold standard for ... leader in specialized medical strengthening equipment. ... a lease with the physician or practice who prescribe ...
Breaking Medicine Technology: